KMID : 0578320120340060577
|
|
Molecules and Cells 2012 Volume.34 No. 6 p.577 ~ p.583
|
|
Identification of a Novel Cell-Penetrating Peptide from Human Phosphatidate Phosphatase LPIN3
|
|
Lim Sang-Ho
Kim Won-Ju Kim Yeon-Ho Choi Je-Min
|
|
Abstract
|
|
|
Biomolecules such as proteins, DNA, and RNA are mac-romolecules and can not cross the cell membrane. How-ever, cell-penetrating peptide (CPP) has been shown to deliver therapeutic biomolecules successfully into cells. The various and widely used CPPs including TAT, VP22, and Antp are mostly non-human originated CPPs, and are limited by their potential toxicity and immunogenicity. We report here on a newly identified novel cell-penetrating sequence (LPIN; RRKRRRRRK) from the nuclear localization sequence (NLS) of human nuclear phosphatase, LPIN3. LPIN-EGFP recombinant protein was concentration- and time-dependently delivered into cells and localized to the nucleus as well as the cytoplasm. It penetrated the cell membrane by lipid raft-mediated endocytosis by binding to heparan sulfate proteoglycan. LPIN-EGFP was successfully delivered into primary mouse splenocytes in vitro and it could be delivered into various tissues including liver, kidney, and intestine in mice after intra-peritoneal injection. This re-search suggests that LPIN-CPP could be used in a drug delivery system to deliver therapeutic biomolecules including peptides, proteins, DNA, and RNA and without the limitations of non-human originated CPPs such as TAT-CPP.
|
|
KEYWORD
|
|
CPP, drug delivery system, LPIN, PTD
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|